Eukles Asset Management First Trust Nyse Arca Biotechn Transaction History

Eukles Asset Management

$223 Million
Q1 2025

A detailed history of Eukles Asset Management transactions in First Trust Nyse Arca Biotechn stock. As of the latest transaction made, Eukles Asset Management holds 212 shares of FBT stock, worth $34,191. This represents 0.02% of its overall portfolio holdings.

Number of Shares

212

Previous 215 1.4%

Holding current value

$34,191

Previous $35,000 2.86%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$164.86 - $182.19 $494 - $546	-3 Reduced 1.4%	212 $36,000
Q4 2024 Jan 29, 2025	SELL	$161.65 - $178.69 $1,454 - $1,608	-9 Reduced 4.02%	215 $35,000
Q3 2024 Oct 29, 2024	SELL	$152.39 - $172.91 $21,029 - $23,861	-138 Reduced 38.12%	224 $38,000
Q2 2024 Aug 01, 2024	SELL	$141.52 - $156.4 $707 - $782	-5 Reduced 1.36%	362 $55,000
Q1 2024 May 13, 2024	SELL	$145.08 - $160.46 $21,036 - $23,266	-145 Reduced 28.32%	367 $56,000
Q4 2023 Jan 31, 2024	SELL	$132.5 - $158.45 $2,650 - $3,169	-20 Reduced 3.76%	512 $80,000
Q2 2023 Aug 01, 2023	SELL	$151.19 - $159.79 $5,291 - $5,592	-35 Reduced 6.17%	532 $81,000
Q1 2023 Apr 28, 2023	SELL	$147.92 - $165.37 $18,046 - $20,175	-122 Reduced 17.71%	567 $87,000
Q4 2022 Jan 27, 2023	SELL	$132.87 - $159.04 $6,909 - $8,270	-52 Reduced 7.02%	689 $106,000
Q1 2022 Apr 27, 2022	SELL	$137.27 - $163.07 $411 - $489	-3 Reduced 0.4%	741 $111,000
Q4 2021 Feb 10, 2022	SELL	$153.09 - $169.84 $29,852 - $33,118	-195 Reduced 20.77%	744 $120,000
Q3 2021 Oct 28, 2021	SELL	$164.82 - $176.04 $22,250 - $23,765	-135 Reduced 12.57%	939 $156,000
Q2 2021 Jul 27, 2021	SELL	$157.67 - $176.2 $5,203 - $5,814	-33 Reduced 2.98%	1,074 $185,000
Q1 2021 Apr 27, 2021	SELL	$156.06 - $184.84 $2,965 - $3,511	-19 Reduced 1.69%	1,107 $178,000
Q4 2020 Jan 26, 2021	SELL	$152.75 - $174.52 $1,069 - $1,221	-7 Reduced 0.62%	1,126 $189,000
Q3 2020 Oct 29, 2020	SELL	$150.39 - $180.07 $26,318 - $31,512	-175 Reduced 13.38%	1,133 $178,000
Q2 2020 Jul 29, 2020	SELL	$127.11 - $171.8 $10,423 - $14,087	-82 Reduced 5.9%	1,308 $219,000
Q1 2020 Apr 22, 2020	SELL	$114.56 - $156.02 $47,771 - $65,060	-417 Reduced 23.08%	1,390 $182,000
Q4 2019 Jan 24, 2020	SELL	$120.34 - $154.01 $174,372 - $223,160	-1,449 Reduced 44.5%	1,807 $269,000
Q3 2019 Oct 29, 2019	SELL	$123.44 - $131.99 $6,048 - $6,467	-49 Reduced 1.48%	3,256 $403,000
Q2 2019 Aug 01, 2019	SELL	N/A	-12 Reduced 0.36%	3,305 $465,000
Q1 2019 Apr 23, 2019	SELL	N/A	-280 Reduced 7.78%	3,317 $500,000
Q4 2018 Jan 22, 2019	BUY	N/A	3,597 New	3,597 $447,000

Others Institutions Holding FBT

# of Institutions

297

Shares Held

3.78M

Call Options Held

14K

Put Options Held

200

View Full List

About FIRST TRUST NYSE ARCA BIOTECHN

Ticker FBT
Sector ETFs
Industry ETFs

More about FBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eukles Asset Management with notifications on news.

Account

Eukles Asset Management First Trust Nyse Arca Biotechn Transaction History